Prostate Cancer - Results from #23560

Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance - Abstract March 23, 2012

An overview of prostate diseases and their characteristics specific to Asian men - Abstract March 23, 2012

Rationing in urologic oncology: Lessons from sipuleucel-T for advanced prostate cancer - Abstract March 22, 2012

Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies - Abstract March 22, 2012

Biopsy and implantation of the seminal vesicles - Abstract March 22, 2012

The efficacy of exercise in reducing depressive symptoms among cancer survivors: A meta-analysis - Abstract March 22, 2012

Functional outcomes in African-Americans following robotic-assisted radical prostatectomy (RARP) - Abstract March 22, 2012

Simulation optimization of PSA-threshold based prostate cancer screening policies - Abstract March 22, 2012

Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer - Abstract March 22, 2012

Prostate cancer risk prediction in a urology clinic in Mexico - Abstract March 22, 2012

Do additional cores from MRI cancer-suspicious lesions to systematic 12-core transrectal prostate biopsy give better cancer detection? - Abstract March 21, 2012

Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy - Abstract March 21, 2012

Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance - Abstract March 21, 2012

Urinary morbidity after permanent prostate brachytherapy - Impact of dose to the urethra vs. sources placed in close vicinity to the urethra - Abstract March 21, 2012

The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: Implications for treatment selection - Abstract March 21, 2012

Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions - Abstract March 21, 2012

Long-term outcomes after high-dose postprostatectomy salvage radiation treatment - Abstract March 21, 2012

Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A Surveillance, Epidemiology and End Results patterns of care study - Abstract March 21, 2012

Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy - Abstract March 20, 2012

Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: A 12-year follow-up study - Abstract March 20, 2012

Page 1179 of 1306